Sorry for the acronymony....wrong TLA.
| LIFE CV-19: Effects on life, work, and sports
- Thread starter BAMANEWSBOT
- Start date
Fixed my spelling, thanks again Sir,
Seasonal flu stats below.
www.cdc.gov
Seasonal flu stats below.
Preliminary In-Season 2021-2022 Flu Burden Estimates
CDC's weekly cumulative in-season estimates of flu cases, medical visits, hospitalizations and deaths in the United States.
www.cdc.gov
If they sugar coat the whole situation its going to get worse. People need to understand that they need to take precautions that they need to follow the health guidelines to prevent the spread. I just wish they can find a vaccine soon. I just want to get back to watching and playing basketball again.
POTUS Trump is the Command in Chief, the buck stops with him.
I'm not clear what point your making with paragraph 3. Spell it out, I'm from Alabama
POTUS Trump is the Command in Chief, the buck stops with him.
I'm not clear what point your making with paragraph 3. Spell it out, I'm from Alabama
The point in paragraph 3 where Dr Fauci points out at the time the mortality rate is akin to seasonal flu, as believed by him on 2/28/20. He was then and now the main adviser to President Trump on COVID-19.
Hey, I am born and raised and still live in Al.
Sorry that it seemed I was directly my comments towards you, wasn’t my intentions. I’m puzzled how some are getting it and some aren’t too
No worries bubba. Hope you are on the upswing of this thing. Sorry for what you're having to deal with.
Another potential drug for coronavirus in the works.
www.npr.org
Scientists are reporting promising results for a new drug to treat COVID-19.
The drug is known as EIDD-2801. It works by interfering with the coronavirus' ability to make copies of itself once it infects a cell. In that regard it's similar to remdesivir, a drug currently being tested in COVID-19 patients.
EIDD-2801 has one major advantage over remdesivir: It can be taken as a pill, whereas remdesivir must be given intravenously.
Researchers from Emory University in Atlanta; the University of North Carolina at Chapel Hill; and Vanderbilt University Medical Center in Nashville, Tenn., first tested EIDD-2801 in cells cultured in the laboratory. When those tests were encouraging, they gave the drug to mice that had been infected with coronaviruses that cause either SARS or MERS, and showed that it reduced the amount of virus in their bodies. In addition, the mice gained weight, another good sign.
The researchers say they were unable to test EIDD-2801 in mice infected with the virus that causes COVID-19 because right now most mice are not susceptible to infection with that virus.
A paper describing the new results appeared online today in the journal Science Translational Medicine.
Vanderbilt University Medical Center virologist Mark Denison, one of paper's authors, says there's already been a lot of research on other coronaviruses, so he's not worried that testing the drugs in animals will turn up any problems.
Timothy Sheahan of the University of North Carolina, another one of the paper's authors, said in a press release that "in normal times, testing in non-human primates would be the obvious next step on the road to human testing. Since these are not normal times, this could be skipped and evaluated under compassionate use and established clinical trials in people. The goal is to directly attack the virus, lessen symptoms, decrease pathogenesis and save lives."
Promising Drug On The Horizon For COVID-19
A drug that's been tested against the coronaviruses that cause MERS and SARS and shown to have valuable antiviral properties appears to be potent against the COVID-19 virus as well.
www.npr.org
Scientists are reporting promising results for a new drug to treat COVID-19.
The drug is known as EIDD-2801. It works by interfering with the coronavirus' ability to make copies of itself once it infects a cell. In that regard it's similar to remdesivir, a drug currently being tested in COVID-19 patients.
EIDD-2801 has one major advantage over remdesivir: It can be taken as a pill, whereas remdesivir must be given intravenously.
Researchers from Emory University in Atlanta; the University of North Carolina at Chapel Hill; and Vanderbilt University Medical Center in Nashville, Tenn., first tested EIDD-2801 in cells cultured in the laboratory. When those tests were encouraging, they gave the drug to mice that had been infected with coronaviruses that cause either SARS or MERS, and showed that it reduced the amount of virus in their bodies. In addition, the mice gained weight, another good sign.
The researchers say they were unable to test EIDD-2801 in mice infected with the virus that causes COVID-19 because right now most mice are not susceptible to infection with that virus.
A paper describing the new results appeared online today in the journal Science Translational Medicine.
Vanderbilt University Medical Center virologist Mark Denison, one of paper's authors, says there's already been a lot of research on other coronaviruses, so he's not worried that testing the drugs in animals will turn up any problems.
Timothy Sheahan of the University of North Carolina, another one of the paper's authors, said in a press release that "in normal times, testing in non-human primates would be the obvious next step on the road to human testing. Since these are not normal times, this could be skipped and evaluated under compassionate use and established clinical trials in people. The goal is to directly attack the virus, lessen symptoms, decrease pathogenesis and save lives."
I am all for trying something that gives people hope even if there is a limited sample size. The hard thing to me on this one is that 98+% of people get better anyway.
Yea, 98% do get better but have a lot of pain with the virus. If I had it I would want to try it. For the 2% I would try it before I die.
Good data here.
On blacks dying at higher rates, I also believe they have higher rates of obesity, diabetes, and cardiovascular disease. Those three are the things I have seen documented in all states as the top 3 or 3 of the top 5 factors involved in the majority of deaths.
That's what Dr Birx and Dr Fauci said last night as well, underlying health issues.
Vitamin D may play a role in this as well, as I understand lighter skin makes vitamin D faster than darker skin. I mentioned to my mom weeks ago to increase her vitamin D dosage as a way to help boost her system.
The West coast has done an admirable job dealing with this, they were some of the first to implement legit mitigation strategies and the data suggest it's worked thus far.
I'm wondering if the 15 min test is being used on every visitor to the White House.
This reporter has me laughing a bit at her actions. If you're worried so much you have a mask on, what's the point of constantly adjusting and putting your hands near your mask?
At one point a photographer walks by and she leans away from him.
Now she's messing around on her phone taking photos?
This reporter has me laughing a bit at her actions. If you're worried so much you have a mask on, what's the point of constantly adjusting and putting your hands near your mask?
At one point a photographer walks by and she leans away from him.
Now she's messing around on her phone taking photos?
Similar threads
- SEC Sports
- Around the 'Net
- Article
- Question